SecSonar.com

Solventum Corporation (SOLV)

Solventum Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Solventum Corporation (SOLV) is a Medical - Care Facilities company based in US with a market capitalization of $13.2B. Revenue grew 0.9% year-over-year and free cash flow was negative at -$10M. This page tracks SOLV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 22K employees · IPO Apr 1, 2024

Valuation

Valuation & price

$74.26 · as of May 17, 2026 · -13.8% vs 52w high

8.4

P/E ratio

Latest-FY diluted EPS

2.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$85.77$74.13$62.49Jul 25Dec 25Jul 26Jul 7, 25$76.24Jul 9, 25$74.19Jul 11, 25$73.80Jul 15, 25$73.68Jul 17, 25$73.86Jul 21, 25$72.34Jul 23, 25$74.40Jul 25, 25$74.75Jul 29, 25$73.55Jul 31, 25$71.36Aug 4, 25$73.22Aug 6, 25$72.57Aug 11, 25$71.86Aug 13, 25$74.38Aug 15, 25$71.42Aug 19, 25$72.27Aug 21, 25$72.00Aug 25, 25$72.75Aug 27, 25$72.89Aug 29, 25$73.09Sep 3, 25$71.40Sep 5, 25$72.72Sep 9, 25$72.90Sep 11, 25$73.79Sep 16, 25$74.13Sep 18, 25$74.37Sep 22, 25$73.76Sep 24, 25$71.82Sep 26, 25$71.37Sep 30, 25$73.00Oct 2, 25$74.60Oct 6, 25$73.78Oct 8, 25$72.43Oct 10, 25$70.52Oct 14, 25$71.49Oct 16, 25$71.44Oct 21, 25$72.91Oct 23, 25$72.27Oct 27, 25$71.98Oct 29, 25$69.78Oct 31, 25$69.04Nov 4, 25$68.59Nov 6, 25$66.28Nov 10, 25$71.79Nov 12, 25$73.83Nov 14, 25$75.66Nov 18, 25$76.89Nov 20, 25$79.51Nov 25, 25$85.77Nov 28, 25$85.26Dec 2, 25$85.59Dec 4, 25$85.26Dec 8, 25$82.60Dec 10, 25$81.90Dec 12, 25$82.98Dec 16, 25$80.59Dec 18, 25$80.68Dec 22, 25$80.78Dec 24, 25$80.18Dec 29, 25$80.09Jan 2, 26$79.02Jan 6, 26$83.16Jan 8, 26$85.77Jan 12, 26$85.69Jan 14, 26$80.05Jan 16, 26$79.48Jan 21, 26$80.37Jan 23, 26$78.91Jan 27, 26$77.61Jan 29, 26$76.52Feb 2, 26$76.91Feb 4, 26$76.49Feb 9, 26$78.07Feb 11, 26$81.49Feb 13, 26$75.55Feb 18, 26$74.91Feb 20, 26$72.94Feb 24, 26$73.42Feb 26, 26$76.94Mar 2, 26$73.00Mar 4, 26$70.40Mar 6, 26$69.41Mar 10, 26$67.60Mar 12, 26$66.12Mar 17, 26$68.67Mar 19, 26$67.14Mar 23, 26$65.69Mar 25, 26$64.64Mar 27, 26$62.76Mar 31, 26$65.30Apr 2, 26$63.57Apr 7, 26$62.49Apr 9, 26$66.18Apr 13, 26$67.41Apr 15, 26$69.10Apr 17, 26$70.48Apr 22, 26$69.11Apr 24, 26$68.52Apr 28, 26$67.51Apr 30, 26$67.36May 4, 26$67.44May 6, 26$71.00May 8, 26$73.38May 12, 26$75.10May 14, 26$74.42May 18, 26$76.13May 20, 26$76.13May 22, 26$76.83May 28, 26$75.94Jun 1, 26$75.84Jun 3, 26$78.36Jun 5, 26$81.01Jun 9, 26$82.46Jun 11, 26$79.22Jun 15, 26$76.90Jun 17, 26$74.56Jun 22, 26$73.56Jun 24, 26$75.59Jun 26, 26$79.53Jul 2, 26$78.27
$62.4952-week range$86.14
Loading valuation history…

Fundamentals

Key fundamentals

$13.2B

Market cap

0.9%

Revenue growth (YoY)

53.5%

Gross margin

-$10M

Free cash flow (USD)

$4.2B

Net debt

0.5%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$7.3BFY 2021$8.2BFY 2022$8.1BFY 2023$8.2BFY 2024$8.3BFY 2025$8.3B
$7.3B$8.3B

Free cash flow by year

2020 → 2025

FY 2020$1.8BFY 2021$1.9BFY 2022$1.4BFY 2023$1.6BFY 2024$805.0MFY 2025$-10.0M
$1.8B-$10M

Gross margin by year

2021 → 2025

FY 202160.3%FY 202257.8%FY 202357.3%FY 202455.6%FY 202553.5%
60.3%53.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventLegal SettlementJun 5, 2026Filing
  • 8-K eventExecutive Severance Plan EstablishedMay 27, 2026Filing
  • 8-K eventAnnual Shareholder Meeting ResultsMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is Solventum Corporation's market cap?

Solventum Corporation (SOLV) has a market capitalization of $13.2B.

What is SOLV's P/E ratio?

SOLV trades at a price-to-earnings ratio of 8.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is SOLV's price-to-book (P/B) ratio?

SOLV trades at 2.60 times book value per share.

Are insiders buying SOLV stock?

SEC Form 4 filings show no open-market insider buys at Solventum Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Care Facilities

DVA

DaVita Inc.

$12.6B

FMS

Fresenius Medical Care AG & Co. KGaA

$11.6B

THC

Tenet Healthcare Corporation

$15.3B

EHC

Encompass Health Corporation

$10.6B

ENSG

The Ensign Group, Inc.

$9.8B

UHS

Universal Health Services, Inc.

$9.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.